Protocol - Angiogenesis inhibitors - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-01-13 12:04:40 Bristol-Myers Squibb Angiogenesis inhibitors Alkylating antineoplastic agents Endostatin Proteins Gastrointestinal cancer Cetuximab Head and neck cancer Lung cancer Medicine Chemistry Oncology		Protocol #[removed]RAC Presentation E10A (Endostatin Adenovirus) for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck George Yoo, M.D., FACS PI, Head and Neck Surgery, Karmanos Cancer Cen Add to Reading List Source URL: osp.od.nih.gov Download Document from Source Website File Size: 701,35 KB Share Document on Facebook

	A Day in Life at BMS Welcome to A Day in Life at BMS where you will meet leaders from our R&D organization and learn more about research and development at Bristol-Myers Squibb, as well as network with our scientists. To DocID: 1vrK6 - View Document
	NoIN THE Supreme Court of the United States BRISTOL-MYERS SQUIBB COMPANY, PETITIONER, DocID: 1tuCc - View Document
	Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty) DocID: 1tut4 - View Document
	September 2003 USA Bristol-Myers Squibb Medical Imaging DocID: 1sKnx - View Document
	May 2003 Bristol-Myers Squibb Medical Imaging 331 Treble Cove Road N. Billerica, Massachusetts 01862 DocID: 1sC8T - View Document